Source study found

Story checked

Viagra's cousin could help muscle cells stay primed for regeneration (opens in a new tab)

medicalxpress.com · 2026-10-26

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

4 supported
2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail

The story

Viagra's cousin could help muscle cells stay primed for regeneration

medicalxpress.com · 2026-10-26

The story’s checkable claims.

Read the original story

NewsLink checks it

Mixed

Every claim we could check holds up. Four of six claims match the study. This overall rating is based only on the claims we could check. Two claims the study doesn't address.

4 supported
2 not covered

Open claim evidence

The source study

Prolonged tadalafil exposure promotes skeletal muscle myogenesis and regulates early myogenic markers activation in C2C12 cell lines

Molecular Biology Reports · 2026

Open source record Open in Tessa

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

Reading mode

Scan verdicts. Open evidence only when needed.

Browse by verdict

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6Not coveredThe article says tadalafil appeared to expand precursor cells while holding back maturation, and it boosted IL-6 release, which helps activate muscle stem cells.View evidenceHide evidence

Why this verdict

The profile supports the broad idea that tadalafil promoted a proliferative/less differentiated phenotype and that IL6 was upregulated. However, at abstract depth the profile does not establish that IL-6 specifically was released rather than expressed, and it does not verify the explanatory claim that the IL-6 change helps activate muscle stem cells in this experiment.

Study evidence

Prolonged tadalafil (1 µM, up to 7 days) increased proliferation and survival and reduced cell death in C2C12 cultures.

Study evidence

Prolonged tadalafil exposure (1 µM, up to 7 days) in C2C12 myoblasts was associated with increased expression of Sirt3 and IL6 and decreased expression of myostatin and TGFβ; myokine release was also analyzed.

Claim 2 of 6Not coveredBy days three, five and seven, treated cultures contained significantly more cells than untreated ones, and scratch tests suggested the treated cells migrated faster to close the gap within 24 hours.View evidenceHide evidence

As stateddays three, five and seven; within 24 hours

Why this verdict

The profile supports significantly increased proliferation/survival in tadalafil-treated cultures, but it does not provide the specific day 3, 5, and 7 cell-count framing. More importantly, scratch-wound migration assays and 24-hour gap closure are not described in the abstract-level paper profile, so that part cannot be verified at this depth.

Study evidence

Prolonged tadalafil (1 µM, up to 7 days) increased proliferation and survival and reduced cell death in C2C12 cultures.

Claim 3 of 6SupportedA recent study published in Molecular Biology Reports examined whether long-term tadalafil exposure could help muscle cells multiply faster, survive stress, and remain primed to repair muscle damage.View evidenceHide evidence

Why this verdict

The abstract-level profile supports that the study examined prolonged tadalafil exposure in C2C12 muscle precursor cells and measured proliferation, viability/survival, myogenic activation, and differentiation. The phrasing about being 'primed to repair muscle damage' is interpretive, but it is hedged and consistent with the paper's regeneration/therapeutic framing rather than presented as proven in vivo repair.

Study evidence

Prolonged tadalafil (1 µM, up to 7 days) increased proliferation and survival and reduced cell death in C2C12 cultures.

Study evidence

The authors suggest tadalafil has potential as an adjuvant pharmacological therapy for muscle-wasting disorders based on observed effects in C2C12 myoblasts (increased proliferation/survival, sustained early myogenic markers, altered myokine and regulator expression).

Claim 4 of 6SupportedThe researchers grew mouse muscle cells in petri dishes and exposed them to 1 µM tadalafil for up to seven days, tracking growth, survival, and genetic activity over time.View evidenceHide evidence

As statedup to seven days; 1 µM tadalafil

Why this verdict

The paper profile states that C2C12 myoblast cultures were treated with 1 µM tadalafil for up to seven days and analyzed for proliferation, viability/survival, myogenesis activation, marker expression, and myokine-related outcomes. 'Petri dishes' is a lay description of the in vitro culture setting.

Study evidence

Prolonged tadalafil (1 µM, up to 7 days) increased proliferation and survival and reduced cell death in C2C12 cultures.

Study evidence

Claim 5 of 6SupportedTadalafil-treated cultures had more living mouse muscle precursor cells and fewer dead cells than untreated cells, and after seven days fewer cells fused into mature muscle fibers.View evidenceHide evidence

As statedup to seven days

Why this verdict

The profile reports increased proliferation and survival with reduced cell death after prolonged tadalafil treatment, and reduced formation of MHC-positive multinucleated myotubes after prolonged exposure, consistent with fewer cells undergoing terminal myogenic differentiation.

Study evidence

Prolonged tadalafil (1 µM, up to 7 days) increased proliferation and survival and reduced cell death in C2C12 cultures.

Claim 6 of 6SupportedThe researchers reported higher Pax7 and Myf6 levels, along with reduced myostatin and TGF-β, in tadalafil-exposed cells, but said studies in living organisms are needed to determine whether the effects have therapeutic value.View evidenceHide evidence

Why this verdict

The abstract-level profile reports sustained higher Pax7 and Myf6 after seven days, downregulation of myostatin and TGFβ, and emphasizes that therapeutic implications are extrapolations from in vitro data without in vivo or clinical validation. The story's caveat that living-organism studies are needed is consistent with those limitations.

Study evidence

Prolonged tadalafil (1 µM, up to 7 days) increased proliferation and survival and reduced cell death in C2C12 cultures.

Study evidence

Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

The paper also raises anti-doping or performance-enhancement misuse concerns.
This supporting interpretive implication is present in the paper profile but not reflected in the story presentation.
From Narrative interpretation/extrapolation from in-vitro findings

7 things the story did carry across

The core experiment used an in vitro C2C12 mouse myoblast model treated with 1 µM tadalafil for up to seven days.
Prolonged tadalafil exposure increased proliferation/survival and reduced cell death in the C2C12 cultures.
Tadalafil enhanced early myogenic markers, including sustained Pax7 and Myf6, while delaying terminal differentiation and reducing MHC-positive multinucleated myotube formation.
The paper reports molecular/myokine-marker changes: increased Sirt3 and IL6 and decreased myostatin and TGFβ.
The paper interprets the in vitro findings as suggesting possible adjuvant therapeutic relevance for muscle-wasting disorders.
A major limitation is that the findings come from a single in vitro C2C12 cell-line system and may not generalize to primary cells, animals, or humans.
The paper does not test in vivo regenerative capacity, muscle function, clinical efficacy, safety, dosing, or pharmacokinetics.

Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

Evidence read

study summary

Lead result

in vitro

1Lead resultin vitroProlonged tadalafil exposure alters C2C12 myoblast growth/survival and myogenic progression, enhancing early myogenic program while delaying terminal differentiation.in vitro cell-culture time-course drug exposureExpand

In plain English

In C2C12 myoblast cultures treated continuously with 1 µM tadalafil for up to seven days, the authors report increased proliferation and survival with reduced cell death, concomitant upregulation of early myogenic markers (including sustained Pax7 and Myf6 at day 7) and molecular shifts (↑Sirt3, ↑IL6, ↓myostatin, ↓TGFβ), but reduced formation of MHC-positive multinucleated myotubes consistent with delayed terminal differentiation.

Key findings

Prolonged tadalafil (1 µM, up to 7 days) increased proliferation and survival and reduced cell death in C2C12 cultures.
Tadalafil exposure enhanced expression of early myogenic factors and maintained higher Pax7 and Myf6 expression after seven days.

What this piece can’t prove

Findings are from a single in vitro cell line (C2C12) and may not generalize to primary cells or in vivo muscle tissue.

3 further details could not be confirmed from the summary.

2in vitroProlonged tadalafil exposure modulates associated metabolic/myokine and pro-/anti-myogenic signaling markers (e.g., Sirt3, IL6, myostatin, TGFβ) during C2C12 myogenesis.in vitro cell culture time-courseExpand

In plain English

In an in vitro C2C12 myoblast time-course (1 µM tadalafil up to 7 days), the authors report upregulation of Sirt3 and IL6 and downregulation of myostatin and TGFβ; myokine release was also analyzed.

Key findings

Prolonged tadalafil exposure (1 µM, up to 7 days) in C2C12 myoblasts was associated with increased expression of Sirt3 and IL6 and decreased expression of myostatin and TGFβ; myokine release was also analyzed.

What this piece can’t prove

Findings are reported only in an in vitro C2C12 cell model; translation to in vivo settings is uncertain.
Abstract lacks methodological detail (specific assays, normalization, replicates, statistical measures) and quantitative effect sizes for the reported marker changes.

1 further detail could not be confirmed from the summary.

3otherThe findings imply potential therapeutic relevance for muscle-wasting disorders and raise concerns for performance-enhancing misuse (anti-doping relevance).Narrative interpretation/extrapolation from in-vitro findingsExpand

In plain English

The paper's conclusions interpret in-vitro C2C12 results to propose that prolonged tadalafil exposure could be used as an adjuvant therapy for muscle-wasting disorders and that the same regenerative effects raise concerns about potential performance-enhancing misuse, warranting evaluation by anti-doping agencies. These statements are presented as interpretive implications rather than new in vivo or clinical evidence.

Key findings

The authors suggest tadalafil has potential as an adjuvant pharmacological therapy for muscle-wasting disorders based on observed effects in C2C12 myoblasts (increased proliferation/survival, sustained early myogenic markers, altered myokine and regulator expression).
The authors raise concerns that tadalafil's enhancement of muscle regenerative machinery could be misused as a performance-enhancing agent and recommend evaluation by anti-doping agencies.

What this piece can’t prove

Interpretive implications extend beyond the scope of the reported in-vitro experiments; no supporting in vivo or clinical data are described in the provided text.
Potential therapeutic benefit and anti-doping risk are not empirically tested within human/animal studies in this report.
The conclusions rely on mechanistic and marker-based changes in a single cell-line model, which may not generalize to whole-organism physiology.

Finally, the search trail

Method layer